跳转至内容
Merck
CN

G5166

PNGase F Glycosidase

Removes N-linked glycans, suitable for mass spectrometry, from Elizabethkingia miricola

别名:

N-糖苷酶 F, 肽N-糖苷酶

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

化学文摘社编号:
UNSPSC Code:
12352204
NACRES:
NA.32
MDL number:
Specific activity:
≥20000 units/mg protein
Biological source:
bacterial (Elizabethkingia miricola)
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

糖苷酶F from Elizabethkingia miricola, buffered aqueous solution

biological source

bacterial (Elizabethkingia miricola)

Quality Level

conjugate

(N-linked)

form

buffered aqueous solution

specific activity

≥20000 units/mg protein

mol wt

36 kDa

shipped in

wet ice

storage temp.

2-8°C

General description

PNGase F(肽N-糖苷酶F)剪切天冬酰胺连接糖蛋白,生成无糖肽链和分离的全长寡糖。

Application

PNGase F(来自米尔伊丽莎白菌)已用于蛋白的去糖基化。
用于使蛋白质脱糖基。

Biochem/physiol Actions

如果糖基化天冬酰胺基团在其氨基和羧基端被多肽链取代,则从糖蛋白中切割整个聚糖。

Physical form

以溶于 20 mM Tris HCl (pH 7.5)、50 mM NaCl 和 1 mM EDTA 的溶液形式提供

Other Notes

一个单元将在37℃,pH7.5下通过SDS-PAGE监测,在1分钟内催化1纳摩尔变性核糖核酸酶B释放N-连接的寡糖。 PNGase F活性的一个 Sigma 单位等于1 IUB毫单位。


Still not finding the right product?


pictograms

Health hazard

signalword

Danger

hcodes

Hazard Classifications

Resp. Sens. 1

存储类别

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

法规信息

常规特殊物品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


商品

Explore strategies for releasing N-linked glycans with PNGase F, PNGase A & native & sequential deglycosylation with endoglycosidases & exoglycosidases.

相关内容

Glycobiology and Glycoproteomics Brochure


A novel humanized GLP-1 receptor model enables both affinity purification and Cre-LoxP deletion of the receptor
Jun LS, et al.
PLoS ONE, 9(4), e93746-e93746 (2014)
Identification and Characterization of a Novel Prokaryotic Peptide N-GLYCOSIDASE FROM ELIZABETHKINGIA MENINGOSEPTICA
Sun G, et al.
The Journal of Biological Chemistry, 290(12), 7452-7462 (2015)
Gyoung Nyoun Kim et al.
PLoS pathogens, 17(12), e1010092-e1010092 (2021-12-17)
The development of safe and effective vaccines to prevent SARS-CoV-2 infections remains an urgent priority worldwide. We have used a recombinant vesicular stomatitis virus (rVSV)-based prime-boost immunization strategy to develop an effective COVID-19 vaccine candidate. We have constructed VSV genomes



全球贸易项目编号

货号GTIN
G5166-100UN04061833633441
G5166-50UN04061832856568